Friends of Alzheimer's Research Professor of Psychiatry, Psychiatry, University of WA
Psychiatry
Dr. Elaine R. Peskind, MD
|
|
Give Review
Elaine Peskind is an expert in the field of Psychiatry. She graduated from University of Washington School of Medicine. Elaine Peskind is a published physician. She published 80 publications, including: 'Biofluid Biomarkers of Mild Traumatic Brain Injury: Whither Plasma Tau.'
Publications
- Biofluid Biomarkers of Mild Traumatic Brain Injury: Whither Plasma Tau.
- Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.
- Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease.
- Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ42 using Meso Scale Discovery Assays for Alzheimer's Disease.
- Rarity of the Alzheimer Disease-Protective APP A673T Variant in the United States.
- Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease: A Genome-Wide Association Study.
- Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.
- Influence of lifestyle modifications on age-related free radical injury to brain.
- Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.
- Targeted Discovery and Validation of Plasma Biomarkers of Parkinson's Disease.
- Cross-Sectional and Longitudinal Relationships Between Cerebrospinal Fluid Biomarkers and Cognitive Function in People Without Cognitive Impairment From Across the Adu...
- Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults.
- Neuroimaging, Behavioral, and Psychological Sequelae of Repetitive Combined Blast/Impact Mild Traumatic Brain Injury in Iraq and Afghanistan War Veterans.
- Traumatic Brain Injury, Neuroinflammation, and Post-Traumatic Headaches.
- Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects.
- Military- and sports-related mild traumatic brain injury: an overview.
- Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment.
- MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma.
- Blast Exposure Causes Early and Persistent Aberrant Phospho- and Cleaved-Tau Expression in a Murine Model of Mild Blast-Induced Traumatic Brain Injury.
- Cerebrospinal fluid norepinephrine and cognition in subjects across the adult age span.
- GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer's Disease.
- Military- and sports-related mild traumatic brain injury: clinical presentation, management, and long-term consequences.
- DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease.
- TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ɛ3/ɛ3.
- Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease.
- Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer array.
- Temporal Relationship Between Depression and Dementia: Findings From a Large Community-Based 15-Year Follow-up Study.
- Salivary Tau Species are Potential Biomarkers of Alzheimer's Disease.
- Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.
- Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy.
- Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers.
- Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression.
- The Role of Norepinephrine in Differential Response to Stress in an Animal Model of Posttraumatic Stress Disorder.
- Cerebrocerebellar hypometabolism associated with repetitive blast exposure mild traumatic brain injury in 12 Iraq war Veterans with persistent post-concussive symptoms.
- Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.
- Validation of consensus panel diagnosis in dementia.
- CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.
- YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.
- Prazosin treatment of trauma nightmares and sleep disturbance in soldiers deployed in Iraq.
- Age-varying association between statin use and incident Alzheimer's disease.
- Glycoproteomics in neurodegenerative diseases.
- Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression.
- Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings.
- Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects.
- Cerebrospinal fluid: when is it worthwhile to do a lumbar puncture?
- Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease.
- Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers.
- CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases.
- Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study.
- Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of...
- Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or prog...
- Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.
- A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.
- Salivary cortisol and memory function in human aging.
- Beneficial effects of prazosin for visual hallucinations associated with chronic cocaine abuse.
- Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach.
- The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.
- Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.
- Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition.
- Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder.
- Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype.
- Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy b...
- Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease.
- Characterization of proteome of human cerebrospinal fluid.
- Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults.
- Safety and acceptability of the research lumbar puncture.
- Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
- Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid.
- Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque.
- Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study.
- The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial.
- Management of depression in long-term care of patients with Alzheimer's disease.
- Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease.
- Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.
- Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study.
- Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder.
- Pharmacologic treatments of dementia.
- A Luminex Assay Detects Amyloid β Oligomers in Alzheimer's Disease Cerebrospinal Fluid.
Schools
University of Washington
University Wa Med Center
Doctors Specialties
- Geriatric Psychiatry
- Psychiatry
Accepted Insurances
Education
-
University of Washington -
University of Washington School of Medicine
Hospital
-
University of Washington Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Elizabeth A. Noll, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen M. Thielke, MD |
|
|
Dr. Shannon W. Simmons, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shannon L. Corbin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Murray A. Raskind, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer K. Seibert, MD |
|
|
Dr. William R. Bennett, MD |
|
|
Dr. Linda Luster, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vasant G. Halarnakar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jesse D. Markman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicole I. Sussman, MD |